Replies to post #7715 on Repros Therapeutics Inc (RPRX)

[DewDiligence]

Allowing a mid-stage clinical trial to continue with restricted dosing is hardly indicative of ultimate FDA approval; quite the opposite, actually.

This is a done deal. Try a little more current DD sport.

Based on your reply, I would respectfully submit that you haven’t done yours.